New hope for hard-to-treat head and neck cancer: triple therapy trial underway
NCT ID NCT06378177
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new three-drug combination for people with advanced head and neck cancer that came back or spread after platinum chemotherapy. The drugs aim to boost the immune system and attack cancer cells directly. About 64 adults will take part to see if the treatment is safe and shrinks tumors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anhui Cancer Hospital
Hefei, Anhui, 230000, China
-
Beijing Cancer Hospital
Beijing, Beijing Municipality, 100142, China
-
Beijing Tongren Hospital Affiliated to Capital Medical University
Beijing, Beijing Municipality, 100730, China
-
Fujian cancer hospital
Fuzhou, Fujian, 350014, China
-
Guangxi Medical University Cancer Hospital
Nanning, Guangxi, 530021, China
-
Henan cancer hospital
Zhengzhou, Henan, 450008, China
-
Hunan Cancer Hospital
Changsha, Hunan, 410031, China
-
Liaoning cancer hospital
Shenyang, Liaoning, 110042, China
-
Shanghai Oriental Hospital
Shanghai, Shanghai Municipality, 200123, China
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510120, China
-
The Second Xiangya Hospital, Central South University
Changsha, Hunan, 410011, China
-
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430030, China
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430000, China
-
West China Hospital of Sichuan University
Chengdu, Sichuan, 610041, China
-
Xiangya Hospital Central South University
Changsha, Hunan, 410008, China
-
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, 310022, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new nucleotide analogue boost cancer treatment?
- Can a short course of immunotherapy and radiation shrink head and neck tumors before surgery?
- Can a Two-Drug attack shrink Hard-to-Treat head and neck tumors?
- Could a genetic marker guide future cancer therapies in taiwan?
- Could a cheaper copy of keytruda work just as well against cancer?
- Smart T-Cell engager aims to outsmart tumors in first human test